With clinical data in hand, trio of Bay Area biotechs raise collective $1.1 billion

The companies are pushing forward against fibrosis in fatty liver disease, to stop a dangerous kidney condition or to prevent pneumonia, and their latest news was rewarded by Wall Street investors.

Source: bizjournals.com Health Care:Biotechnology headlines - January 31, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news